Clarification of the mechanism underlying y-secretase cleavage by presenilin complexes
Clarification of the mechanism underlying y-secretase cleavage by presenilin complexes
批准号:
13210067
负责人:
NISHIMURA Masaki
金额:
$31.68万
依托单位国家:
日本
项目类别:
Grant-in-Aid for Scientific Research on Priority Areas
财政年份:
2001
资助国家:
日本
项目状态:
已结题
起止时间:
2001 至 2004
中文摘要
早老素是家族性阿尔茨海默病(FAD)的致病分子,是γ-分泌酶活性所必需的。γ-分泌酶介导淀粉样前体蛋白(APP)的膜内切割,导致称为淀粉样β(Aβ)的致病肽的产生。由于Aβ_(42/3)在AD的发病机制中起着重要作用,因此阐明这一机制一直是AD研究的热点。我们已经揭示,早老素通过与nicastrin和其它蛋白质一起形成大分子复合物来介导APP和Notch的γ-分泌酶切割(Nat Cell Biol,2001),并且另一种组分PEN-2增强γ-分泌酶底物的可及性(J Neurochem,2004)。早老素中引起FAD的突变通过改变γ-分泌酶活性增加了较长Aβ_<42/43>的产生,但其潜在机制尚不清楚。利用早老素1(PS1)的随机突变筛选,我们鉴定了包括R278 I-PS1和L435 H-PS1在内的五种独特突变体,其仅产生高水平的Aβ_,<43>但不支持生理性PS1内蛋白水解或Aβ_<40>产生(J Biol Chem,2005)。细胞生物学研究和药理学研究表明,PS1突变和γ-分泌酶抑制剂对特异性的影响通常是通过复合物的构象变化介导的。我们的研究结果表明,小分子可以被设计成诱导交替的PS复合物构象,这更有利于Aβ_<40>而不是致病性Aβ_<42/43>的产生。此外,我们报道早老素通过结合FKBP 38并减少线粒体中的抗凋亡Bcl-2而发挥促凋亡作用。此外,早老素的FAD突变增强了这种促凋亡活性,使神经元对脑中的凋亡刺激物敏感(AgNOMol Genet,出版中)。
英文摘要
Presenilins, causative molecules for familial Alzheimer's disease (FAD), are required for y-secretase activity. y- Secretase mediates intramembrane cleavage of amyloid precursor protein (APP), resulting in generation of pathogenic peptides named amyloid β(Aβ). The clarification of this mechanism is a central issue in AD research, because the longer Aβ ending at residue 42 or 43 (Aβ_<42/3>) are thought to play a critical role in the pathogenesis of AD. We have revealed that presenilins mediate y-secretase cleavage of APP and Notch by forming macromolecular complexes together with nicastrin and other proteins (Nat Cell Biol, 2001), and that another component PEN-2 enhances the accessibility of the y-secretase substrates (J Neurochem, 2004). FAD- causing mutations in the presenilins increase production of longer Aβ_<42/43> by altering y-secretase activity, although the underlying mechanism remains unknown. Using a random mutagenesis screen of presenilin 1 (PS1), we identified five unique mutants including R278I-PS1 and L435H-PS1, which exclusively generated a high level of Aβ_<43> but that did not support physiological PS1 endoproteolysis or Aβ_<40> generation (J Biol Chem, 2005). Cell biological investigation and pharmacological study using the inhibitors suggest that the effects of PS1 mutations and y-secretase inhibitors on the specificity are commonly mediated through a conformational change in the complex. Our results suggest that small molecules could be designed to induce alternate PS complex conformations that are more favourable to the generation of Aβ_<40> rather than pathogenic Aβ_<42/43>. Additionally, we reported that presenilins exert a pro-apoptotic effect by binding to FKBP38 and reducing anti- apoptotic Bcl-2 in the mitochondria. Furthermore, FAD mutations of presenilins enhance this pro-apoptotic activity, sensitizing neurons to apoptotic stimuli in brains (Hum Mol Genet, in press).
期刊论文(70)
专著(0)
科研奖励(0)
会议论文
登录
查看更多内容
β-and γ-secretases as therapeutic targets for Alzheimer's disease.
β-和γ-分泌酶作为阿尔茨海默病的治疗靶点。
DOI:
--
发表时间:
2004
期刊:
Igaku no Ayumi 208(5)
影响因子:
--
作者:
[Wang HQ, Nakaya Y, Du Z, Yamane T, Shirane M, Kudo T, Takeda M, Takebayashi K, Noda Y, Nakayama KI, Nishimura M., 西村正樹, 西村正樹, Yoichi Araki, Hirohisa Shiraishi, 西村正樹, Nishimura M.]
通讯作者:
Nishimura M.
Alzheimer病:Aβの生成抑制による治療戦略
阿尔茨海默病:通过抑制 Aβ 产生的治疗策略
DOI:
--
发表时间:
2004
期刊:
最新医学 59・7
影响因子:
--
作者:
[Shiraishi H, et al., 西村正樹]
通讯作者:
西村正樹
Therapeutric strategy for Alzheimer disease : Inhibition of Amyloid β generation.
阿尔茨海默病的治疗策略:抑制β淀粉样蛋白的生成。
DOI:
--
发表时间:
2004
期刊:
Saishin Igaku 59(7)
影响因子:
--
作者:
[Shiraishi H, Sai X, Wang HQ, Maeda Y, Kurono Y, Nishimura M, Yanagisawa K, Komano H., Nishimura M.]
通讯作者:
Nishimura M.
Follistatin-related gene (FLRG) expression in human endometrium : sex steroid hormones regulate the expression of FLRG in cultured human endometrial stromal cells.
人子宫内膜中卵泡抑素相关基因(FLRG)的表达:性类固醇激素调节培养的人子宫内膜基质细胞中 FLRG 的表达。
DOI:
--
发表时间:
2003
期刊:
J Clin Endocrinol Metab 88・9
影响因子:
--
作者:
[Shiraishi H, et al., 西村正樹, Hua-Qin Wang]
通讯作者:
Hua-Qin Wang
DOI:
10.1093/hmg/ddi195
发表时间:
2005-07-01
期刊:
HUMAN MOLECULAR GENETICS
影响因子:
3.5
作者:
[Wang, HQ, Nakaya, Y, Nishimura, M]
通讯作者:
Nishimura, M
共 27 条
Neuron-specific mechanism for production and secretion of amyloid-beta and therapeutic regulation of its deposition
-
批准号:26430070
-
项目类别:Grant-in-Aid for Scientific Research (C)
-
资助金额:$3.24万
-
财政年份:2014
-
负责人:NISHIMURA Masaki
-
依托单位:
Development of therapeutic strategy for Alzheimer's disease by targeting amyloid precursor protein C99
-
批准号:23500445
-
项目类别:Grant-in-Aid for Scientific Research (C)
-
资助金额:$3.33万
-
财政年份:2011
-
负责人:NISHIMURA Masaki
-
依托单位:
Protective Actions of Adiponectin on Cerebral Ischemia-reperfusion Injury.
-
批准号:20791008
-
项目类别:Grant-in-Aid for Young Scientists (B)
-
资助金额:$2.75万
-
财政年份:2008
-
负责人:NISHIMURA Masaki
-
依托单位:
Clarification of Molecular Mechanism For-AmyloidβGeneration in Alzheimer's Disease
-
批准号:13470035
-
项目类别:Grant-in-Aid for Scientific Research (B)
-
资助金额:$8.19万
-
财政年份:2001
-
负责人:NISHIMURA Masaki
-
依托单位:
国内基金
海外基金
登录
查看更多内容
电刺激调控下的诱导多向潜能干细胞移植对缺血性卒中的神经修复作用及其Presenilin1信号机制研究
-
批准号:81701230
-
项目类别:青年科学基金项目
-
资助金额:20.0万元
-
批准年份:2017
-
负责人:刘倩
-
依托单位:
应用心肌特异基因敲除小鼠探讨presenilin 1在心力衰竭中的功能与机制
-
批准号:81760076
-
项目类别:地区科学基金项目
-
资助金额:34.0万元
-
批准年份:2017
-
负责人:胡淑婷
-
依托单位:
早老素Presenilin介导的免疫调控及其在神经退行性疾病中的作用
-
批准号:31470040
-
项目类别:面上项目
-
资助金额:30.0万元
-
批准年份:2014
-
负责人:钱旻
-
依托单位:
膜蛋白酶Presenilin在膀胱癌恶性进展过程中的表达及分子机制研究
-
批准号:81302231
-
项目类别:青年科学基金项目
-
资助金额:22.0万元
-
批准年份:2013
-
负责人:瓦斯里江·瓦哈甫
-
依托单位:
Presenilin功能缺失对大脑线粒体及凋亡途径的影响及其分子基础
-
批准号:31171019
-
项目类别:面上项目
-
资助金额:65.0万元
-
批准年份:2011
-
负责人:赵政
-
依托单位: